On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…
On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
On Jul. 24, 2001, the largest-ever prostate cancer prevention study was launched by the National Cancer Institute and…
On Apr. 24, 2001, Genome Canada announced $136 million in funding to support 22 large-scale research projects and…
In 2001, SynCardia Systems, a private company formed to commercialize the Jarvik 7 artificial heart, was founded by…
On Jul. 31, 2000, Genome British Columbia was founded as one of six Genome Canada centres across the…
In 2000, Eli Lilly and Takeda Chemical launched Actos, an oral anti diabetes agent. In 2005, a PROactive…
On May 25, 1999. the Study of Tamoxifen and Raloxifene, or STAR, one of the largest breast cancer…
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
In 1998, the The Prostate Centre at VGH, now known as the Vancouver Prostate Centre, was founded. The…
In 1995, researchers led by Dr. Peter St. George-Hyslop at the University of Toronto discovered and cloned two…
On Apr. 16, 1993, the U.S. Centers for Disease Control (CDC) reported that from November 15, 1992, through…
In 1989, transgenic fast-growing salmon were created. In 2015, the U.S. Food and Drug Administration (FDA) approved a…
In 1989, McGill University researcher Dr. Bernard Belleau developed the antiviral drug 3TC (Lamivudine), which became a critical…
On Aug. 6, 1986, Bill Schroeder from Jasper, Indiana, the second human recipient of the Jarvik 7 artificial…
In 1986, while teaching a graduate course at the University of Alberta, Dr. Tyrrell found clues that might…
On Oct. 11, 1985, scientists in Canada and Massachusetts reported discovering the first genetic marker for the widespread…
On Apr. 6, 1985, Bill Schroeder from Jasper, Indiana, the second human recipient of the Jarvik 7 artificial…
On Mar. 8, 1984, two articles describing the cloning of the T-Cell Receptor (TCR) by Tak Wah Mak…
In 1983, Dr. Tak Wah Mak co-discovered the T-cell receptor and the gene that produces it. Dr. Mak…
In 1982, Merck Frosst Canada was created through the restructuring of Merck & Co., Charles E. Frosst, and…
On Jul. 27, 1979, the last cases of wild type 1 poliovirus occurred in the U.S. among unvaccinated…
In 1979, the Honourable Peter Lougheed introduced an Act to the Alberta Legislature to establish the Alberta Heritage…
In 1977, Dr. Henry Friesen of McGill University discovered the hormone prolactin and defined its role as a…
In 1976, St. Jude Medical was founded by Manny Villafana in Little Canada, a suburb of Saint Paul….
In 1975, Stanford Medicine researchers discovered link between exercise and increased ‘good’ (HDL) cholesterol levels. The Coronary Primary…
In 1974, Professor Philip Seeman MD, PhD, DSc FRSC, Order of Canada, an ACNP Member Emeritus reported the…
In 1970, Dr. Calvin Stiller conducted one of the first clinical trials studying the effectiveness of the immunosuppressive…